Programme

Explore our interdisciplinary programme. Build your own schedule by adding sessions to your calendar.

Please note: Session times are not final, and are subject to change.

Van Beinum Zaal

Manvir Singh

Helena Aicher, Susanne Prinz, Óscar Soto Angona, Max Wolff

Psychedelics in psychiatry and psychotherapy

Damiaan Denys

Peter Gasser

Harriet de Wit

Grace Blest-Hopley

Celia Morgan, Rayyan Zafar, Alison Chapman, David Erritzoe, Rebecca Harding

Daan Keiman, Duncan Still, Simon Ruffell, Léla Mosemghvlishvili

Mariavittoria Mangini

Industry, Policy and Access Pathways

Josh Hardman

Floris Wolswijk

Adana Omagua Kambeba, Bu'u Kennedy, Glauber Loures de Assis

Challenging Experiences

Lisa Maria Jöbstl

Leonie Schneider, Ian Roullier, Caroline Lilley

Amy Atkins, Leonie Schneider, Jo Giblin, Ian Roullier

Daan F Oostveen

Cecilie Byholt Endresen, Brian Stafford, Sam Gandy, Simon Ruffell

Ido Cohen, Nir Tadmor, Maria Papaspyrou, Johanna Sopanen

Psychedelics in Religious Contexts

Jonathan David

PAT: Qualitative Research in Underserved Populations

Sabrina Cluesman

Clayton Olash

Daniel Kruger, Dee Dee Goldpaugh, Pat Song, Daniel Kruger

Xiaofan Sun, Minsu Yoo, Jennifer Docherty

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

Manvir Singh

Helena Aicher, Susanne Prinz, Óscar Soto Angona, Max Wolff

Psychedelics in psychiatry and psychotherapy

Damiaan Denys

Peter Gasser

Harriet de Wit

Grace Blest-Hopley

Celia Morgan, Rayyan Zafar, Alison Chapman, David Erritzoe, Rebecca Harding

Daan Keiman, Duncan Still, Simon Ruffell, Léla Mosemghvlishvili

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

Mariavittoria Mangini

Industry, Policy and Access Pathways

Josh Hardman

Floris Wolswijk

Adana Omagua Kambeba, Bu'u Kennedy, Glauber Loures de Assis

Challenging Experiences

Lisa Maria Jöbstl

Leonie Schneider, Ian Roullier, Caroline Lilley

Amy Atkins, Leonie Schneider, Jo Giblin, Ian Roullier

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

Van Beinum Zaal

Daan F Oostveen

Cecilie Byholt Endresen, Brian Stafford, Sam Gandy, Simon Ruffell

Ido Cohen, Nir Tadmor, Maria Papaspyrou, Johanna Sopanen

Psychedelics in Religious Contexts

Jonathan David

PAT: Qualitative Research in Underserved Populations

Sabrina Cluesman

Clayton Olash

Daniel Kruger, Dee Dee Goldpaugh, Pat Song, Daniel Kruger

Xiaofan Sun, Minsu Yoo, Jennifer Docherty

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

Programme

OPENing

From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic use

From Experience to Outcome: Psychological Change Processes in Psychedelic Research

Altered States and the Future of Psychopathology: Psychedelics in Historical and Philosophical Perspective

Common Factors of Psychotherapy in Psychedelic-Assisted Therapy (PAT)

From getting high to getting healthy: Recent research on psychoactive drugs

The 51% Blind Spot: Psychedelics, Women's Health and the Opportunity We Must Not Miss

Rewiring Addiction: Psychedelic Therapy from Brain Circuits to Lived Recovery

Toward a western psychedelic practice lineage: standards, care, and the future of practitioner education

Not “The Mad Virgin of Psychedelia”

The state of the psychedelic industry and policy

Are reimbursement pathways ready for licensed psychedelic therapies in Europe?

From Renaissance to Confluence: A paradigm shift from the Global South in psychedelic science.

Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences

When therapy falls short: a qualitative study of psychotherapy after challenging psychedelic experiences and the need for psychedelic-informed therapy

From Patients to Partners: Early Insights from a Patient-Led Care Model Following Psychedelic Treatment (Supported by the Norrsken Mind Participant Fellowship)

Clinical trial experts by experience: A dose of reality (Supported by the Norrsken Mind Participant Fellowship)

Live HandPan Meditation with Reo Matsumoto

The psychedelic humanities: a posthuman proposal for the community of psychedelic professionals

Remembering Our Original Nature – Ecological Dimensions of Psychedelics, Health, and the Self

Jungian perspectives on psychedelic experience: dynamics, integration, and education

Crossing orthodox boundaries: the emergence of ayahuasca use in the ultra-orthodox (Haredi) world

“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelics

Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adults

Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders

Psychedelics and the intimate self: Sexuality, gender, and relationships

Asian Psychedelia: Family, Governance, and Postcolonial Tensions in Psychedelic Treatments

OPENing

From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic use

From Experience to Outcome: Psychological Change Processes in Psychedelic Research

Altered States and the Future of Psychopathology: Psychedelics in Historical and Philosophical Perspective

Common Factors of Psychotherapy in Psychedelic-Assisted Therapy (PAT)

From getting high to getting healthy: Recent research on psychoactive drugs

The 51% Blind Spot: Psychedelics, Women's Health and the Opportunity We Must Not Miss

Rewiring Addiction: Psychedelic Therapy from Brain Circuits to Lived Recovery

Toward a western psychedelic practice lineage: standards, care, and the future of practitioner education

Not “The Mad Virgin of Psychedelia”

The state of the psychedelic industry and policy

Are reimbursement pathways ready for licensed psychedelic therapies in Europe?

From Renaissance to Confluence: A paradigm shift from the Global South in psychedelic science.

Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences

When therapy falls short: a qualitative study of psychotherapy after challenging psychedelic experiences and the need for psychedelic-informed therapy

From Patients to Partners: Early Insights from a Patient-Led Care Model Following Psychedelic Treatment (Supported by the Norrsken Mind Participant Fellowship)

Clinical trial experts by experience: A dose of reality (Supported by the Norrsken Mind Participant Fellowship)

Live HandPan Meditation with Reo Matsumoto

The psychedelic humanities: a posthuman proposal for the community of psychedelic professionals

Remembering Our Original Nature – Ecological Dimensions of Psychedelics, Health, and the Self

Jungian perspectives on psychedelic experience: dynamics, integration, and education

Crossing orthodox boundaries: the emergence of ayahuasca use in the ultra-orthodox (Haredi) world

“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelics

Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adults

Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders

Psychedelics and the intimate self: Sexuality, gender, and relationships

Asian Psychedelia: Family, Governance, and Postcolonial Tensions in Psychedelic Treatments

OPENing

From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic use

From Experience to Outcome: Psychological Change Processes in Psychedelic Research

Altered States and the Future of Psychopathology: Psychedelics in Historical and Philosophical Perspective

Common Factors of Psychotherapy in Psychedelic-Assisted Therapy (PAT)

From getting high to getting healthy: Recent research on psychoactive drugs

The 51% Blind Spot: Psychedelics, Women's Health and the Opportunity We Must Not Miss

Rewiring Addiction: Psychedelic Therapy from Brain Circuits to Lived Recovery

Toward a western psychedelic practice lineage: standards, care, and the future of practitioner education

Not “The Mad Virgin of Psychedelia”

The state of the psychedelic industry and policy

Are reimbursement pathways ready for licensed psychedelic therapies in Europe?

From Renaissance to Confluence: A paradigm shift from the Global South in psychedelic science.

Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences

When therapy falls short: a qualitative study of psychotherapy after challenging psychedelic experiences and the need for psychedelic-informed therapy

From Patients to Partners: Early Insights from a Patient-Led Care Model Following Psychedelic Treatment (Supported by the Norrsken Mind Participant Fellowship)

Clinical trial experts by experience: A dose of reality (Supported by the Norrsken Mind Participant Fellowship)

Live HandPan Meditation with Reo Matsumoto

The psychedelic humanities: a posthuman proposal for the community of psychedelic professionals

Remembering Our Original Nature – Ecological Dimensions of Psychedelics, Health, and the Self

Jungian perspectives on psychedelic experience: dynamics, integration, and education

Crossing orthodox boundaries: the emergence of ayahuasca use in the ultra-orthodox (Haredi) world

“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelics

Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adults

Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders